First Time Loading...

Fusion Antibodies PLC
LSE:FAB

Watchlist Manager
Fusion Antibodies PLC Logo
Fusion Antibodies PLC
LSE:FAB
Watchlist
Price: 6 GBX -5.88% Market Closed
Updated: May 31, 2023

Operating Margin

According to Fusion Antibodies PLC's latest financial reports the company's operating margin is -46%.

-45.8%
Current
-31.6%
Average
7.4%
Industry
What is Operating Margin?

Operating Margin History

Statistics
Operating Margin

1 Year 3 Years 5 Years
Average -33.9% -31.6% -39.2%
Median -28.4% -28.4% -29.2%
Min -45.8% -45.8% -75.2%
Max -27.6% -24.9% -24.9%

History Chart
Operating Margin

Operating Margin Distribution

Operating Margin Distribution
Life Sciences Tools & Services Industry

Operating Margin Across Competitors

Operating Margin Comparison
Fusion Antibodies PLC Competitors

Country UK
Market Cap 1.6M GBP
Operating Margin
-46%
Country US
Market Cap 198B USD
Operating Margin
17%
Country US
Market Cap 166B USD
Operating Margin
27%
Country CH
Market Cap 42.3B CHF
Operating Margin
25%
Country KR
Market Cap 55.5T KRW
Operating Margin
31%
Country US
Market Cap 36.8B USD
Operating Margin
13%
Country US
Market Cap 34.7B USD
Operating Margin
24%
Country US
Market Cap 30.7B USD
Operating Margin
2%
Country US
Market Cap 29B USD
Operating Margin
29%
Country CN
Market Cap 192B CNY
Operating Margin
24%
Country US
Market Cap 25B USD
Operating Margin
25%

Profitability Report

View the profitability report to see the full profitability analysis for Fusion Antibodies PLC.

See Also

Similar Stocks
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
=
Operating Profit
/
Revenue